Current best practices and rationalistic perspectives in causation-based prevention, early detection and multidisciplinary treatment of breast and gastric cancer

Volume 13
Number 1
CURRENT ISSUE
NEXT ISSUE

 

 
ARTICLE
TYPE
ABSTRACT
PDF
Pages
  CURRENT ISSUE
Developing new targeted drugs for resectable gastric cancer
EDITORIAL
1-7
Pancreatic cancer genome analysis. New predictive approaches.
NEWS & VIEWS
8-14
Developing personalized novel therapies for pancreatic cancer.
NEWS & VIEWS
15-20
Validation of the Memorial Sloan-Kettering Cancer Center nomogram in the prediction of recurrence risk after treatment in Ductal Carcinoma in Situ of the breast.
Original Article
21-30
Static and dynamic analysis with Next-Generation Sequencing.
FOCUS
31-36
Recent approval of new targeted drugs for non-metastatic cancers improves oncological outcomes.
FOCUS
37-42
Breakthrough blood test for early diagnosis, screening, patient monitoring and therapeutic response prediction.
Special Report
43-48
Genome analysis for the development of novel gastric cancer biomarkers.
Special Report
49-54
Trastazumab – emtasine for HER2-positive breast cancer patients and development of new therapies.
PERSPECTIVE
55-70

Online ISSN : 1109 - 7647
   Print ISSN : 1109 - 7655

 

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.



Search only trustworthy HONcode health websites:

last update: 31 March 2018